Collegium Pharma Inc. (coll 2.875 02/15/29)
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$1118.20avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Collegium Pharma Inc. (coll 2.875 02/15/29) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Boussard & Gavaudan Investment Management LLP ($8.0M).
- Company
- Collegium Pharma Inc. (coll 2.875 02/15/29)
- CUSIP
- 19459JAC8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 1,120 shares bought, net +1,120 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Boussard & Gavaudan Investment Management LLP | 2.51% | Add +18.7% | 7,120 | $8.0M |
"% of holder's portfolio" is COLLEGIUM PHARMA INC (COLL 2.875 02/15/29)'s weight in each manager's 13F, not the share of Collegium Pharma Inc. (coll 2.875 02/15/29) the manager owns.